Identification of an anti-inflammatory protein from Faecalibacterium prausnitzii, a commensal bacterium deficient in Crohn's disease.
about
Structural robustness of the gut mucosal microbiota is associated with Crohn's disease remission after surgeryBifidobacteria and Butyrate-Producing Colon Bacteria: Importance and Strategies for Their Stimulation in the Human GutThe Role of Gut Microflora and the Cholinergic Anti-inflammatory Neuroendocrine System in Diabetes MellitusMolecular Players Involved in the Interaction Between Beneficial Bacteria and the Immune SystemMicrobiota-Specific CD4CD8αα Tregs: Role in Intestinal Immune Homeostasis and Implications for IBDProbiotics as Complementary Treatment for Metabolic DisordersInteraction of obesity and inflammatory bowel diseaseGut microbiota and colorectal cancer.Introduction to the human gut microbiotaDifferential effects of antiretrovirals on microbial translocation and gut microbiota composition of HIV-infected patientsFunctional Characterization of Novel Faecalibacterium prausnitzii Strains Isolated from Healthy Volunteers: A Step Forward in the Use of F. prausnitzii as a Next-Generation Probiotic.Roles for Intestinal Bacteria, Viruses, and Fungi in Pathogenesis of Inflammatory Bowel Diseases and Therapeutic Approaches.The complex interplay of diet, xenobiotics, and microbial metabolism in the gut: Implications for clinical outcomes.Reduced diversity and altered composition of the gut microbiome in individuals with myalgic encephalomyelitis/chronic fatigue syndrome.Childhood undernutrition, the gut microbiota, and microbiota-directed therapeutics.A reduction in the butyrate producing species Roseburia spp. and Faecalibacterium prausnitzii is associated with chronic kidney disease progression.A preliminary investigation on the relationship between gut microbiota and gene expressions in peripheral mononuclear cells of infants with autism spectrum disorders.Convergence of External Crohn's Disease Risk Factors on Intestinal Bacteria.Impact of Different Fecal Processing Methods on Assessments of Bacterial Diversity in the Human Intestine.Could gut microbiota serve as prognostic biomarker associated with colorectal cancer patients' survival? A pilot study on relevant mechanism.Microbial Anti-Inflammatory Molecule (MAM) from Faecalibacterium prausnitzii Shows a Protective Effect on DNBS and DSS-Induced Colitis Model in Mice through Inhibition of NF-κB Pathway.Characterization of cervico-vaginal microbiota in women developing persistent high-risk Human Papillomavirus infection.Deciphering interactions between the gut microbiota and the immune system via microbial cultivation and minimal microbiomes.Distinct gut microbiota profiles in patients with primary sclerosing cholangitis and ulcerative colitis.Probiotics and Disease: A Comprehensive Summary-Part 3, Cardiometabolic Disease and Fatigue Syndromes.Review article: the pathogenesis of pouchitis.Modifiable Environmental Factors in Inflammatory Bowel Disease.The prebiotic concept and human health: a changing landscape with riboflavin as a novel prebiotic candidate?Fecal microbiota transplantation in inflammatory bowel disease: the quest for the holy grail.Probiotics, gut microbiota, and their influence on host health and disease.Formation of propionate and butyrate by the human colonic microbiota.Faecalibacterium prausnitzii: from microbiology to diagnostics and prognostics.Applications of Genetically Modified Immunobiotics with High Immunoregulatory Capacity for Treatment of Inflammatory Bowel Diseases.The Impact of Exclusive Enteral Nutrition (EEN) on the Gut Microbiome in Crohn's Disease: A Review.Gut-liver axis and sterile signals in the development of alcoholic liver disease.More than just a gut feeling: constraint-based genome-scale metabolic models for predicting functions of human intestinal microbes.Gut-CNS-Axis as Possibility to Modulate Inflammatory Disease Activity-Implications for Multiple SclerosisMediterranean diet and faecal microbiota: a transversal study.Using murine colitis models to analyze probiotics-host interactions.Reduction in fecal microbiota diversity and short-chain fatty acid producers in Methicillin-resistant Staphylococcus aureus infected individuals as revealed by PacBio single molecule, real-time sequencing technology.
P2860
Q24658549-B5658194-32A5-40FA-8AB2-1FD94982C6FAQ26742179-3E18048F-AEDA-4067-9245-F0F449F1A559Q26745148-CC39D514-0B83-4A6B-9640-C7984AAE335CQ26774703-FFCF8CA6-E289-4CF9-A294-3098B8E8A5B9Q26779169-5B980AEF-40EA-4829-9A08-791CC9096D5CQ26795371-3CB1A4BE-9FD8-4AF4-9D10-55B71B149700Q28072225-5CE80854-8F32-4E20-BFE4-C8D782C6102EQ30239806-E7D0561E-85C1-4A5B-A8D4-E8C122EDE09DQ33693158-1D84071F-6BFC-4FD3-8771-43A59125C94DQ33787675-6AAC8379-F122-4C21-9C38-7927A2BE9BA2Q33857259-B1CAD261-3AC8-43C1-865D-1DD1007403B7Q33906911-6942F496-A459-4687-A2A6-B8F96DCB5778Q35947598-00824857-DC1D-447C-B88C-2EDF88480DC5Q36060516-CE472F21-9193-4FB7-A0D0-C7222DE62E05Q36060707-D2CB4488-BBFC-41A0-8F28-5D1C133CD508Q36081100-8719E231-C7A8-4ADF-B363-34348536A33CQ36118889-F817FD0E-7506-4A83-9B74-31EA3C72CBDDQ36242017-F65840ED-463E-4350-8BBD-75490845D7B8Q37351918-F0C3FF93-CAD9-40AB-9D49-674F34A47797Q37564679-A4C7503E-4AD8-409F-A501-A9AF3BC4BD12Q37617472-B44D79DF-1822-4ABC-A072-25D7C79D6F81Q38599101-FB779202-FE5E-40CB-9BDB-825CAD3330AAQ38600883-8B66D17B-2903-4184-B110-C209E834EFADQ38663475-AC9968B0-8777-4A86-8A3C-EDD56B1D8738Q38754711-AA7479F4-88D1-4C4B-8ECB-B1918BDC0E0BQ38828436-745005AE-BB6B-448A-AD69-F2E433D98F10Q38843247-9E71181F-FF61-48FD-8DD3-18E6005B5594Q38886978-29BB6F1C-2EF4-45D8-95D8-6BF853DCEDB4Q38909454-24B80573-64ED-41D4-B02D-B3111145A96FQ38921638-92F99B51-1162-4B59-8F37-2A6CBDE804DDQ39032599-56481920-049B-4FB1-902B-066E2930DC7BQ39065664-5C5C28F2-9BF1-495B-90C0-CAA080EF75F3Q39127400-D055852F-4912-44E2-A0C7-E255E859221EQ39281074-25B50F10-F549-41E3-A735-68011099E777Q39290975-34AC0401-8D4C-4898-8CC0-2B3AE1A82C93Q39433303-B6B64910-6691-46DE-921C-22CDC72C68D6Q39434933-C91B097E-F551-4E42-A5BC-7E3B191414DEQ39802329-66AC9F4D-73D3-46E6-953E-9C0917246D91Q40084224-45638C8F-2F84-4900-848F-C3CD1E5B8DD3Q40232925-21D0E1D8-F77B-4C42-94F0-501811D94A0E
P2860
Identification of an anti-inflammatory protein from Faecalibacterium prausnitzii, a commensal bacterium deficient in Crohn's disease.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Identification of an anti-infl ...... deficient in Crohn's disease.
@ast
Identification of an anti-infl ...... deficient in Crohn's disease.
@en
type
label
Identification of an anti-infl ...... deficient in Crohn's disease.
@ast
Identification of an anti-infl ...... deficient in Crohn's disease.
@en
prefLabel
Identification of an anti-infl ...... deficient in Crohn's disease.
@ast
Identification of an anti-infl ...... deficient in Crohn's disease.
@en
P2093
P2860
P50
P1433
P1476
Identification of an anti-infl ...... m deficient in Crohn's disease
@en
P2093
D Rainteau
E Quévrain
G Chassaing
J M Chatel
J Tailhades
P2860
P304
P356
10.1136/GUTJNL-2014-307649
P407
P50
P577
2015-06-04T00:00:00Z